Cargando…
Scale-up of the Accrual to Clinical Trials (ACT) network across the Clinical and Translational Science Award Consortium: a mixed-methods evaluation of the first 18 months
INTRODUCTION: The Clinical and Translational Science Award (CTSA) Program is a Consortium of nearly 60 academic medical research centers across the USA and a natural network for evaluating the spread and uptake of translational research innovation across the Consortium. METHODS: Dissemination of the...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057421/ https://www.ncbi.nlm.nih.gov/pubmed/33948228 http://dx.doi.org/10.1017/cts.2020.505 |
_version_ | 1783680832115834880 |
---|---|
author | Morrato, Elaine H. Lennox, Lindsay A. Sendro, Elaina R. Schuster, Anne L. Pincus, Harold A. Humensky, Jennifer Firestein, Gary S. Nadler, Lee M. Toto, Robert Reis, Steven E. |
author_facet | Morrato, Elaine H. Lennox, Lindsay A. Sendro, Elaina R. Schuster, Anne L. Pincus, Harold A. Humensky, Jennifer Firestein, Gary S. Nadler, Lee M. Toto, Robert Reis, Steven E. |
author_sort | Morrato, Elaine H. |
collection | PubMed |
description | INTRODUCTION: The Clinical and Translational Science Award (CTSA) Program is a Consortium of nearly 60 academic medical research centers across the USA and a natural network for evaluating the spread and uptake of translational research innovation across the Consortium. METHODS: Dissemination of the Accrual to Clinical Trials (ACT) Network, a federated clinical informatics data network for population-based cohort discovery, began January 2018 across the Consortium. Diffusion of innovation theory guided dissemination design and evaluation. Mixed-methods assessed the spread and uptake across the Consortium through July 1, 2019 (n = 48 CTSAs). Methods included prospective time activity tracking (Kaplan–Meier curves), and survey and qualitative interviews. RESULTS: Within 18 months, nearly 80% of CTSAs had joined the data network and two-thirds of CTSAs achieving technical readiness had initiated launch to local clinical investigators. Over 10,000 ACT Network queries are projected for 2019; and by 2020, nearly all CTSAs will have joined the network. Median time-from-technical-readiness-to-local-launch was 154 days (interquartile range: 87–225 days]. Quality improvement processes reduced time-to-launch by 35.2% (64 days, p = 0.0036). Lessons learned include: (1) conceptualize dissemination as two-stage adoption demonstrating value for both CTSA hub service providers and clinical investigators; (2) include institutional trial into dissemination strategies so CTSA hubs can refine internal workflows and gather local user feedback endorsement; (3) embrace designing-for-dissemination during technology development; and (4) sustain adaptive dissemination and customer relationship management to keep CTSA hubs and users engaged. CONCLUSIONS: Scale-up and spread of the ACT Network provides lessons learned for others disseminating innovation across the CTSA Consortium. The Network is primed for embedded implementation research. |
format | Online Article Text |
id | pubmed-8057421 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-80574212021-05-03 Scale-up of the Accrual to Clinical Trials (ACT) network across the Clinical and Translational Science Award Consortium: a mixed-methods evaluation of the first 18 months Morrato, Elaine H. Lennox, Lindsay A. Sendro, Elaina R. Schuster, Anne L. Pincus, Harold A. Humensky, Jennifer Firestein, Gary S. Nadler, Lee M. Toto, Robert Reis, Steven E. J Clin Transl Sci Research Article INTRODUCTION: The Clinical and Translational Science Award (CTSA) Program is a Consortium of nearly 60 academic medical research centers across the USA and a natural network for evaluating the spread and uptake of translational research innovation across the Consortium. METHODS: Dissemination of the Accrual to Clinical Trials (ACT) Network, a federated clinical informatics data network for population-based cohort discovery, began January 2018 across the Consortium. Diffusion of innovation theory guided dissemination design and evaluation. Mixed-methods assessed the spread and uptake across the Consortium through July 1, 2019 (n = 48 CTSAs). Methods included prospective time activity tracking (Kaplan–Meier curves), and survey and qualitative interviews. RESULTS: Within 18 months, nearly 80% of CTSAs had joined the data network and two-thirds of CTSAs achieving technical readiness had initiated launch to local clinical investigators. Over 10,000 ACT Network queries are projected for 2019; and by 2020, nearly all CTSAs will have joined the network. Median time-from-technical-readiness-to-local-launch was 154 days (interquartile range: 87–225 days]. Quality improvement processes reduced time-to-launch by 35.2% (64 days, p = 0.0036). Lessons learned include: (1) conceptualize dissemination as two-stage adoption demonstrating value for both CTSA hub service providers and clinical investigators; (2) include institutional trial into dissemination strategies so CTSA hubs can refine internal workflows and gather local user feedback endorsement; (3) embrace designing-for-dissemination during technology development; and (4) sustain adaptive dissemination and customer relationship management to keep CTSA hubs and users engaged. CONCLUSIONS: Scale-up and spread of the ACT Network provides lessons learned for others disseminating innovation across the CTSA Consortium. The Network is primed for embedded implementation research. Cambridge University Press 2020-06-30 /pmc/articles/PMC8057421/ /pubmed/33948228 http://dx.doi.org/10.1017/cts.2020.505 Text en © The Association for Clinical and Translational Science 2020 https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike licence (http://creativecommons.org/licenses/by-nc-sa/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the same Creative Commons licence is included and the original work is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use. |
spellingShingle | Research Article Morrato, Elaine H. Lennox, Lindsay A. Sendro, Elaina R. Schuster, Anne L. Pincus, Harold A. Humensky, Jennifer Firestein, Gary S. Nadler, Lee M. Toto, Robert Reis, Steven E. Scale-up of the Accrual to Clinical Trials (ACT) network across the Clinical and Translational Science Award Consortium: a mixed-methods evaluation of the first 18 months |
title | Scale-up of the Accrual to Clinical Trials (ACT) network across the Clinical and Translational Science Award Consortium: a mixed-methods evaluation of the first 18 months |
title_full | Scale-up of the Accrual to Clinical Trials (ACT) network across the Clinical and Translational Science Award Consortium: a mixed-methods evaluation of the first 18 months |
title_fullStr | Scale-up of the Accrual to Clinical Trials (ACT) network across the Clinical and Translational Science Award Consortium: a mixed-methods evaluation of the first 18 months |
title_full_unstemmed | Scale-up of the Accrual to Clinical Trials (ACT) network across the Clinical and Translational Science Award Consortium: a mixed-methods evaluation of the first 18 months |
title_short | Scale-up of the Accrual to Clinical Trials (ACT) network across the Clinical and Translational Science Award Consortium: a mixed-methods evaluation of the first 18 months |
title_sort | scale-up of the accrual to clinical trials (act) network across the clinical and translational science award consortium: a mixed-methods evaluation of the first 18 months |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057421/ https://www.ncbi.nlm.nih.gov/pubmed/33948228 http://dx.doi.org/10.1017/cts.2020.505 |
work_keys_str_mv | AT morratoelaineh scaleupoftheaccrualtoclinicaltrialsactnetworkacrosstheclinicalandtranslationalscienceawardconsortiumamixedmethodsevaluationofthefirst18months AT lennoxlindsaya scaleupoftheaccrualtoclinicaltrialsactnetworkacrosstheclinicalandtranslationalscienceawardconsortiumamixedmethodsevaluationofthefirst18months AT sendroelainar scaleupoftheaccrualtoclinicaltrialsactnetworkacrosstheclinicalandtranslationalscienceawardconsortiumamixedmethodsevaluationofthefirst18months AT schusterannel scaleupoftheaccrualtoclinicaltrialsactnetworkacrosstheclinicalandtranslationalscienceawardconsortiumamixedmethodsevaluationofthefirst18months AT pincusharolda scaleupoftheaccrualtoclinicaltrialsactnetworkacrosstheclinicalandtranslationalscienceawardconsortiumamixedmethodsevaluationofthefirst18months AT humenskyjennifer scaleupoftheaccrualtoclinicaltrialsactnetworkacrosstheclinicalandtranslationalscienceawardconsortiumamixedmethodsevaluationofthefirst18months AT firesteingarys scaleupoftheaccrualtoclinicaltrialsactnetworkacrosstheclinicalandtranslationalscienceawardconsortiumamixedmethodsevaluationofthefirst18months AT nadlerleem scaleupoftheaccrualtoclinicaltrialsactnetworkacrosstheclinicalandtranslationalscienceawardconsortiumamixedmethodsevaluationofthefirst18months AT totorobert scaleupoftheaccrualtoclinicaltrialsactnetworkacrosstheclinicalandtranslationalscienceawardconsortiumamixedmethodsevaluationofthefirst18months AT reisstevene scaleupoftheaccrualtoclinicaltrialsactnetworkacrosstheclinicalandtranslationalscienceawardconsortiumamixedmethodsevaluationofthefirst18months |